Impact of angiotensin II receptor blocker therapy (olmesartan or valsartan) on coronary atherosclerotic plaque volume measured by intravascular ultrasound in patients with stable angina pectoris

American Journal of Cardiology

Volumn 112, Issue 3, 2013, Pages 363-368

  Ishii, Hideki ^a   Kobayashi, Masakazu ^a   Kurebayashi, Nobutake ^a   Yoshikawa, Daiji ^a   Suzuki, Susumu ^a   Ichimiya, Satoshi ^b   Kanashiro, Masaaki ^b   Sone, Takahito ^c   Tsuboi, Hideyuki ^c   Amano, Tetsuya ^a   Uetani, Tadayuki ^d   Harada, Ken ^a   Marui, Nobuyuki ^d   Murohara, Toyoaki ^a  

^a NAGOYA UNIVERSITY GRADUATE SCHOOL OF MEDICINE   (Japan)

^b Yokkaichi Municipal Hospital   (Japan)

^c OGAKI MUNICIPAL HOSPITAL   (Japan)

^d CHUBU ROSAI HOSPITAL   (Japan)

Author keywords

[No Author keywords available]

Indexed keywords

ADIPONECTIN; BETA ADRENERGIC RECEPTOR BLOCKING AGENT; CALCIUM ANTAGONIST; HEMOGLOBIN A1C; HIGH DENSITY LIPOPROTEIN CHOLESTEROL; ICOSAPENTAENOIC ACID; INSULIN; LOW DENSITY LIPOPROTEIN CHOLESTEROL; OLMESARTAN; PIOGLITAZONE; SULFONYLUREA; VALSARTAN;

ADULT; AGED; ARTICLE; ATHEROSCLEROTIC PLAQUE; BLOOD PRESSURE MEASUREMENT; BODY MASS; BORDERLINE HYPERTENSION; CONTROLLED STUDY; CORONARY ARTERY ATHEROSCLEROSIS; DIASTOLIC BLOOD PRESSURE; FEMALE; FOLLOW UP; HUMAN; INTRAVASCULAR ULTRASOUND; LIPOPROTEIN BLOOD LEVEL; MAJOR CLINICAL STUDY; MALE; MULTICENTER STUDY; PERCUTANEOUS CORONARY INTERVENTION; PRIORITY JOURNAL; RANDOMIZED CONTROLLED TRIAL; STABLE ANGINA PECTORIS; SYSTOLIC BLOOD PRESSURE;

AGED; AGED, 80 AND OVER; ANGINA PECTORIS; ANGIOPLASTY, BALLOON, CORONARY; ANGIOTENSIN II TYPE 1 RECEPTOR BLOCKERS; COMBINED MODALITY THERAPY; CORONARY ARTERY DISEASE; DISEASE PROGRESSION; DOUBLE-BLIND METHOD; FEMALE; HUMANS; HYPERTENSION; IMAGE INTERPRETATION, COMPUTER-ASSISTED; IMIDAZOLES; LONG-TERM CARE; MALE; MIDDLE AGED; TETRAZOLES; ULTRASONOGRAPHY, INTERVENTIONAL; VALINE;

EID: 84880332660     PISSN: 00029149     EISSN: 18791913     Source Type: Journal    
DOI: 10.1016/j.amjcard.2013.03.038     Document Type: Article

References (26)

1. S.E. Nissen, E.M. Tuzcu, P. Schoenhagen, B.G. Brown, P. Ganz, R.A. Vogel, T. Crowe, G. Howard, C.J. Cooper, B. Brodie, C.L. Grines, A.N. DeMaria REVERSAL Investigators Effect of intensive compared with moderate lipid-lowering therapy on progression of coronary atherosclerosis: a randomized controlled trial JAMA 291 2004 1071 1080
2. S.J. Nicholls, C.M. Ballantyne, P.J. Barter, M.J. Chapman, R.M. Erbel, P. Libby, J.S. Raichlen, K. Uno, M. Borgman, K. Wolski, and S.E. Nissen Effect of two intensive statin regimens on progression of coronary disease N Engl J Med 365 2011 2078 2087
3. S. Okazaki, T. Yokoyama, K. Miyauchi, K. Shimada, T. Kurata, H. Sato, and H. Daida Early statin treatment in patients with acute coronary syndrome: demonstration of the beneficial effect on atherosclerotic lesions by serial volumetric intravascular ultrasound analysis during half a year after coronary event: the ESTABLISH Study Circulation 110 2004 1061 1068
4. T. Takayama, T. Hiro, M. Yamagishi, H. Daida, A. Hirayama, S. Saito, T. Yamaguchi, M. Matsuzaki COSMOS Investigators Effect of rosuvastatin on coronary atheroma in stable coronary artery disease: multicenter coronary atherosclerosis study measuring effects of rosuvastatin using intravascular ultrasound in Japanese subjects (COSMOS) Circ J 73 2009 2110 2117
5. M. Miyagi, H. Ishii, R. Murakami, S. Isobe, M. Hayashi, T. Amano, A. Kosuke, T. Ohashi, T. Uetani, T. Matsubara, and T. Murohara Impact of chronic statin therapy on coronary plaque composition at angiographically severe lesions: a non-randomized study focused on history of chronic statin treatment before coronary angioplasty Clin Ther 31 2009 64 73
6. S.E. Nissen, E.M. Tuzcu, P. Libby, P.D. Thompson, M. Ghali, D. Garza, L. Berman, H. Shi, E. Buebendorf, E.J. Topol CAMELOT Investigators Effect of antihypertensive agents on cardiovascular events in patients with coronary disease and normal blood pressure: the CAMELOT study: a randomized controlled trial JAMA 292 2004 2217 2225
7. A. Hirohata, K. Yamamoto, T. Miyoshi, K. Hatanaka, S. Hirohata, H. Yamawaki, I. Komatsubara, M. Murakami, E. Hirose, S. Sato, K. Ohkawa, M. Ishizawa, H. Yamaji, H. Kawamura, S. Kusachi, T. Murakami, K. Hina, and T. Ohe Impact of olmesartan on progression of coronary atherosclerosis a serial volumetric intravascular ultrasound analysis from the OLIVUS (impact of OLmesarten on progression of coronary atherosclerosis: evaluation by intravascular ultrasound) trial J Am Coll Cardiol 55 2010 976 982
8. A. Hirohata, K. Yamamoto, T. Miyoshi, K. Hatanaka, S. Hirohata, H. Yamawaki, I. Komatsubara, E. Hirose, Y. Kobayashi, K. Ohkawa, M. Ohara, H. Takafuji, F. Sano, Y. Toyama, S. Kusachi, T. Ohe, and H. Ito Four-year clinical outcomes of the OLIVUS-Ex (impact of Olmesartan on progression of coronary atherosclerosis: evaluation by intravascular ultrasound) extension trial Atherosclerosis 220 2012 134 138
9. T. Yonetsu, K. Kato, S.J. Kim, L. Xing, H. Jia, I. McNulty, H. Lee, S. Zhang, S. Uemura, Y. Jang, S.J. Kang, S.J. Park, S. Lee, B. Yu, T. Kakuta, and I.K. Jang Predictors for neoatherosclerosis: a retrospective observational study from the optical coherence tomography registry Circ Cardiovasc Imaging 5 2012 660 666
10. T.J. Ryan, W.B. Bauman, J.W. Kennedy, D.J. Kereiakes, S.B. King 3rd, B.D. McCallister, S.C. Smith Jr., and D.J. Ullyot Guidelines for percutaneous transluminal coronary angioplasty. A report of the American Heart Association/American College of Cardiology Task Force on Assessment of Diagnostic and Therapeutic Cardiovascular Procedures (Committee on Percutaneous Transluminal Coronary Angioplasty) Circulation 88 1993 2987 3007
11. M. Kawasaki, H. Takatsu, T. Noda, K. Sano, Y. Ito, K. Hayakawa, K. Tsuchiya, M. Arai, K. Nishigaki, G. Takemura, S. Minatoguchi, T. Fujiwara, and H. Fujiwara In vivo quantitative tissue characterization of human coronary arterial plaques by use of integrated backscatter intravascular ultrasound and comparison with angioscopic findings Circulation 105 2002 2487 2492
12. F. D'Ascenzo, P. Agostoni, A. Abbate, D. Castagno, M.J. Lipinski, G.W. Vetrovec, G. Frati, D.G. Presutti, G. Quadri, C. Moretti, F. Gaita, and G.B. Zoccai Atherosclerotic coronary plaque regression and the risk of adverse cardiovascular events: a meta-regression of randomized clinical trials Atherosclerosis 226 2013 178 185
13. ALLHAT Officers and Coordinators for the ALLHAT Collaborative Research Group Major outcomes in high-risk hypertensive patients randomized to angiotensin-converting enzyme inhibitor or calcium channel blocker vs diuretic: The Antihypertensive and Lipid-Lowering Treatment to Prevent Heart Attack Trial (ALLHAT) JAMA 288 2002 2981 2997
14. A. Zanchetti Bottom blood pressure or bottom cardiovascular risk? How far can cardiovascular risk be reduced? J Hypertens 27 2009 1509 1520
15. I. Sipahi, A. Swaminathan, V. Natesan, S.M. Debanne, D.I. Simon, and J.C. Fang Effect of antihypertensive therapy on incident stroke in cohorts with prehypertensive blood pressure levels: a meta-analysis of randomized controlled trials Stroke 43 2012 432 440
16. S. Mochizuki, B. Dahlöf, M. Shimizu, K. Ikewaki, M. Yoshikawa, I. Taniguchi, M. Ohta, T. Yamada, K. Ogawa, K. Kanae, M. Kawai, S. Seki, F. Okazaki, M. Taniguchi, S. Yoshida, N. Tajima Jikei Heart Study group Valsartan in a Japanese population with hypertension and other cardiovascular disease (Jikei Heart Study): a randomised, open-label, blinded endpoint morbidity-mortality study Lancet 369 2007 1431 1439
17. G. Mancia, G. De Backer, A. Dominiczak, R. Cifkova, R. Fagard, G. Germano, G. Grassi, A.M. Heagerty, S.E. Kjeldsen, S. Laurent, K. Narkiewicz, L. Ruilope, A. Rynkiewicz, R.E. Schmieder, H.A. Struijker Boudier, A. Zanchetti, A. Vahanian, J. Camm, R. De Caterina, V. Dean, K. Dickstein, G. Filippatos, C. Funck-Brentano, I. Hellemans, S.D. Kristensen, K. McGregor, U. Sechtem, S. Silber, M. Tendera, P. Widimsky, J.L. Zamorano, S.E. Kjeldsen, S. Erdine, K. Narkiewicz, W. Kiowski, E. Agabiti-Rosei, E. Ambrosioni, R. Cifkova, A. Dominiczak, R. Fagard, A.M. Heagerty, S. Laurent, L.H. Lindholm, G. Mancia, A. Manolis, P.M. Nilsson, J. Redon, R.E. Schmieder, H.A. Struijker-Boudier, M. Viigimaa, G. Filippatos, S. Adamopoulos, E. Agabiti-Rosei, E. Ambrosioni, V. Bertomeu, D. Clement, S. Erdine, C. Farsang, D. Gaita, W. Kiowski, G. Lip, J.M. Mallion, A.J. Manolis, P.M. Nilsson, E. O'Brien, P. Ponikowski, J. Redon, F. Ruschitzka, J. Tamargo, P. van Zwieten, M. Viigimaa, B. Waeber, B. Williams, J.L. Zamorano The Task Force for the Management of Arterial Hypertension of the European Society of Hypertension, The Task Force for the Management of Arterial Hypertension of the European Society of Cardiology 2007 Guidelines for the Management of Arterial Hypertension: The Task Force for the Management of Arterial Hypertension of the European Society of Hypertension (ESH) and of the European Society of Cardiology (ESC) Eur Heart J 28 2007 1462 1536
18. T. Ogihara, K. Kikuchi, H. Matsuoka, T. Fujita, J. Higaki, M. Horiuchi, Y. Imai, T. Imaizumi, S. Ito, H. Iwao, K. Kario, Y. Kawano, S. Kim-Mitsuyama, G. Kimura, H. Matsubara, H. Matsuura, M. Naruse, I. Saito, K. Shimada, K. Shimamoto, H. Suzuki, S. Takishita, N. Tanahashi, T. Tsuchihashi, M. Uchiyama, S. Ueda, H. Ueshima, S. Umemura, T. Ishimitsu, H. Rakugi Japanese Society of Hypertension Committee The Japanese Society of Hypertension Guidelines for the Management of Hypertension (JSH 2009) Hypertens Res 32 2009 3 107
19. E. Imai, J.C. Chan, S. Ito, T. Yamasaki, F. Kobayashi, M. Haneda, H. Makino ORIENT study investigators Effects of olmesartan on renal and cardiovascular outcomes in type 2 diabetes with overt nephropathy: a multicentre, randomised, placebo-controlled study Diabetologia 54 2011 2978 2986
20. F. Turnbull, B. Neal, C. Algert, J. Chalmers, N. Chapman, J. Cutler, M. Woodward, S. MacMahon Blood Pressure Lowering Treatment Trialists' Collaboration Effects of different blood pressure-lowering regimens on major cardiovascular events in individuals with and without diabetes mellitus: results of prospectively designed overviews of randomized trials Arch Intern Med 165 2005 1410 1419
21. J.J. McMurray, J. Ostergren, K. Swedberg, C.B. Granger, P. Held, E.L. Michelson, B. Olofsson, S. Yusuf, M.A. Pfeffer CHARM Investigators and Committees Effects of candesartan in patients with chronic heart failure and reduced left-ventricular systolic function taking angiotensin-converting-enzyme inhibitors: the CHARM-Added trial Lancet 362 2003 767 771
22. K. Kurokawa, J.C. Chan, M.E. Cooper, W.F. Keane, S. Shahinfar, and Z. Zhang Renin angiotensin aldosterone system blockade and renal disease in patients with type 2 diabetes: a subanalysis of Japanese patients from the RENAAL study Clin Exp Nephrol 10 2006 193 200
23. K. Waseda, Y. Ozaki, H. Takashima, J. Ako, T. Yasukawa, T.F. Ismail, H. Hishida, and T. Ito Impact of angiotensin II receptor blockers on the progression and regression of coronary atherosclerosis: an intravascular ultrasound study Circ J 70 2006 1111 1115
24. K. Sano, M. Kawasaki, Y. Ishihara, M. Okubo, K. Tsuchiya, K. Nishigaki, X. Zhou, S. Minatoguchi, H. Fujita, and H. Fujiwara Assessment of vulnerable plaques causing acute coronary syndrome using integrated backscatter intravascular ultrasound J Am Coll Cardiol 47 2006 734 741
25. S. Julius, S.E. Kjeldsen, M. Weber, H.R. Brunner, S. Ekman, L. Hansson, T. Hua, J. Laragh, G.T. McInnes, L. Mitchell, F. Plat, A. Schork, B. Smith, A. Zanchetti VALUE trial group Outcomes in hypertensive patients at high cardiovascular risk treated with regimens based on valsartan or amlodipine: the VALUE randomised trial Lancet 363 2004 2022 2031
26. Blood Pressure Lowering Treatment Trialists' Collaboration F. Turnbull, B. Neal, M. Pfeffer, J. Kostis, C. Algert, M. Woodward, J. Chalmers, A. Zanchetti, and S. MacMahon Blood pressure-dependent and independent effects of agents that inhibit the renin-angiotensin system J Hypertens 25 2007 951 958